FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to pharmaceutics and cellular technologies, namely to application of zongorin as preparation, which possesses regenerative activity. Development of therapeutic effects of preparation is based on direct stimulating action of alkaloid on resident mesenchymal cells-precursors and increase of production of growth factors, which stimulate progenitor elements, by stromal cells of microenvironment of tissues.
EFFECT: invention has stimulating effect on regeneration of tissues.
6 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
MEDICATION, POSSESSING WOUND-HEALING ACTIVITY | 2012 |
|
RU2481836C1 |
WOUND-HEALING MEDICATION | 2012 |
|
RU2475259C1 |
HAEMOSTIMULATING AGENT | 2013 |
|
RU2535021C1 |
TISSUE REGENERATION STIMULATING AGENT | 2013 |
|
RU2599289C2 |
HEMOSTIMULATING AGENT | 2013 |
|
RU2514648C1 |
HEMOSTIMULATING MEDICATION | 2012 |
|
RU2505308C1 |
CEREBROPROTECTIVE AGENT | 2012 |
|
RU2501562C1 |
CEREBROPROTECTIVE AGENT | 2013 |
|
RU2517282C1 |
CEREBROPROTECTIVE AGENT | 2012 |
|
RU2497540C1 |
REGENERATIVE PROCESS ACCELERATING AGENT | 2008 |
|
RU2372932C1 |
Authors
Dates
2013-02-20—Published
2012-03-11—Filed